Iron Horse Wealth Management’s AbbVie ABBV Stock Holding History

Iron Horse Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$88.4K	Buy	476 +210	+79%	+$39K	0.03%	96
2025 Q1	$55.7K	Buy	266 +104	+64%	+$20.2K	0.02%	116
2024 Q4	$28.8K	Buy	162 +45	+38%	+$8.27K	0.01%	152
2024 Q3	$23.1K	Buy	117 +45	+63%	+$8.4K	0.01%	164
2024 Q2	$12.3K	Hold	72	–	–	﹤0.01%	201
2024 Q1	$13.1K	Buy	72 +45	+167%	+$7.75K	0.01%	176
2023 Q4	$4.18K	Hold	27	–	–	﹤0.01%	284
2023 Q3	$4.03K	Buy	27 +17	+170%	+$2.5K	﹤0.01%	285
2023 Q2	$1.35K	Hold	10	–	–	﹤0.01%	259
2023 Q1	$1.59K	Hold	10	–	–	﹤0.01%	287
2022 Q4	$2K	Buy	+10	New	+$1.53K	﹤0.01%	190
2022 Q3	–	Sell	-76	Closed	-$12K	–	130
2022 Q2	$12K	Hold	76	–	–	0.01%	117
2022 Q1	$12K	Hold	76	–	–	0.01%	123
2021 Q4	$10K	Hold	76	–	–	0.01%	118
2021 Q3	$8K	Hold	76	–	–	0.01%	116
2021 Q2	$9K	Buy	76 +66	+660%	+$7.43K	0.01%	118
2021 Q1	$1K	Hold	10	–	–	﹤0.01%	156
2020 Q4	$1K	Buy	+10	New	+$961	﹤0.01%	153

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Iron Horse Wealth Management's ABBV Position: Q2 2025 in Review

Iron Horse Wealth Management increased its AbbVie (ABBV) stake by 79% in Q2 2025, buying an estimated $39K and bringing the position to 476 shares worth $88.4K. The position accounts for 0.03% of the portfolio, ranked #96.

Iron Horse Wealth Management first reported a position in ABBV in Q4 2020 and has held it in 18 quarters since. 3,780 funds tracked by Wall St. Rank hold ABBV as of Q2 2025.

Iron Horse Wealth Management held 476 shares of AbbVie worth $88.4K as of Q2 2025.
Iron Horse Wealth Management bought 210 AbbVie shares in Q2 2025, an estimated $39K.
AbbVie made up 0.03% of Iron Horse Wealth Management's portfolio in Q2 2025, its #96 holding.
Iron Horse Wealth Management first reported a position in AbbVie in Q4 2020 and has held it in 18 quarters since.
3,780 funds tracked by Wall St. Rank held AbbVie as of Q2 2025.

Based on Iron Horse Wealth Management's 13F filing for Q2 2025, filed 22 Jul 2025.